Clinical Trials Directory

Trials / Completed

CompletedNCT02898038

Acceptability and Tolerance Study of a New Oral Nutritional Supplement (ONS)

Tolerance and Acceptability of AYMES PARIS

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Aymes International Limited · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Tolerance and Acceptability of new oral nutritional supplement - AYMES PARIS

Detailed description

To evaluate tolerance and acceptability of AYMES PARIS in patients requiring supplementary oral nutritional support compared with currently available alternatives, measuring outcomes of GI effects, Compliance, product preference,convenience etc. To obtain data to support an ACBS submissions for AYMES PARIS (to allow for prescription in the community at NHS expense).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAYMES PARISAYMES PARIS is a powdered, high energy, oral nutritional supplement to be mixed with milk as a drink. It provides 320 kcal and 12.2 g protein per 139 ml serving. It is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. It is not designed as a sole source of nutrition.

Timeline

Start date
2015-11-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2016-09-13
Last updated
2016-09-13

Source: ClinicalTrials.gov record NCT02898038. Inclusion in this directory is not an endorsement.

Acceptability and Tolerance Study of a New Oral Nutritional Supplement (ONS) (NCT02898038) · Clinical Trials Directory